Prevalence of Undiagnosed Chronic Obstructive Pulmonary Disease Sufferers in the Region of Murcia
Prevalence of Undiagnosed Sufferers in Murcia :Cross-sectional Study
1 other identifier
observational
1,052
1 country
1
Brief Summary
The purpose of this study is determine the prevalence of undiagnosed Chronic Obstructive Pulmonary Disease (COPD) in population served and with exposure to cigarettes in the Region of Murcia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 22, 2011
CompletedFirst Posted
Study publicly available on registry
June 27, 2011
CompletedDecember 15, 2017
June 1, 2011
3 months
June 22, 2011
December 14, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
FEV1/FVC,Forced Expiratory Volume 1/ Forced Vital Capacity
15 days
Study Arms (1)
Chronic Obstructive Pulmonary Disease
Group of patients seen in consultation not previously diagnosed with COPD, both sexes, aged between 40 and 70 years.
Eligibility Criteria
Group of patients seen in consultation not previously diagnosed with COPD, both sexes, aged between 40 and 70 years.
You may qualify if:
- Aged between 40 and 70 years of both sexes
- With a history of smoking (current or past)
- Do not diagnosed with COPD at the time of completion of study
You may not qualify if:
- Prior diagnosis of COPD or Asthma
- A condition prevents performing spirometry
- Patients displaced
- For those diagnosed with COPD:
- Subject treated in CS there is explicit evidence for the disease
- Subjects who at the time of the consultation arouse suspicion of previously undiagnosed COPD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcialead
- MurciaSaludcollaborator
- Public Health Service, Murciacollaborator
- AstraZenecacollaborator
Study Sites (1)
Fundación para la Formación e Investigación Sanitarias de la Región de Murcia
Murcia, Murcia, 30003, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Asensio Lopez Santiago, MD
Consejeria de sanidad y consumo, Direccion general de planificacion, ordenacion sanitaria y farmaceutica e investigacion.
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2011
First Posted
June 27, 2011
Study Start
February 1, 2010
Primary Completion
May 1, 2010
Study Completion
June 1, 2010
Last Updated
December 15, 2017
Record last verified: 2011-06